CytomX Therapeutics, Inc.
USD3.74
+0.34 (+10.00%)
CEO
Sean A. McCarthy
IPO Date
2015-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.42
Prev. Close
$3.40
Day Low
$3.36
Day High
$3.81
52W Low
$1.72
52W High
$8.21
Market Cap
$0.60B
Volume
2.60M
| 59,000 |
| $2.96 |
| 22 Jun 2026 | Mohindru Mani | director | A-Award | Acquired | 59,000 | $2.96 |
| 22 Jun 2026 | Meyers James R | director | A-Award | Acquired | 59,000 | $2.96 |
| 22 Jun 2026 | Gilbert Halley E | director | A-Award | Acquired | 59,000 | $2.96 |
| 22 Jun 2026 | Ashworth Alan | director | A-Award | Acquired | 59,000 | $2.96 |
| 22 Jun 2026 | Jones Elaine V | director | A-Award | Acquired | 59,000 | $2.96 |
| 17 Jun 2026 | Ogden Christopher | Chief Financial Officer | S-Sale | Disposed | 1,624 | $3.05 |
| 19 Mar 2026 | Chu Yu-Waye | Chief Medical Officer | S-Sale | Disposed | 21,279 | $6.42 |
| 19 Mar 2026 | McCarthy Sean A. | director, officer: CEO | S-Sale | Disposed | 118,969 | $6.42 |